|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Non-cash asset impairment | |||||
| Non-cash restructuring charges | |||||
| Loss on divestiture of asbestos liabilities and certain assets | |||||
| Divestiture of asbestos liabilities and certain assets | |||||
| Loss (gain) on dispositions of long-lived assets | |||||
| Deferred income taxes | |||||
| Other non-cash expenses | |||||
| Actuarial gain on pension and other postretirement benefit obligations | |||||
| Loss on the extinguishment of debt | |||||
| Pension curtailment and settlement | |||||
| Stock-based compensation expense | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables, net | |||||
| Inventories, net | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accruals and other | |||||
| Cash provided by operating activities | |||||
| Investing activities | |||||
| Expenditures for property, plant and equipment | |||||
| Acquisitions, net of cash acquired | |||||
| Proceeds from dispositions of long-lived assets | |||||
| Proceeds from insurance claims | |||||
| Proceeds associated with divestiture of discontinued operations | |||||
| Cash used for investing activities | |||||
| Financing activities | |||||
| Proceeds from borrowings of debt | |||||
| Repayments of debt | |||||
| Dividend received from Spin-Off Transaction of PMC | |||||
| Cash transferred to PMC related to Spin-Off Transaction | |||||
| Payment of debt issuance costs | |||||
| Proceeds from exercise of stock options and ESPP contributions | |||||
| Taxes withheld and paid on employees' share-based payment awards | |||||
| Repurchase of common stock | |||||
| Payment of common stock dividends | |||||
| Cash used for financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
Loading...
